Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
5.045
+0.18
(+3.81%)
USD |
NASDAQ |
Oct 26, 16:00
5.14
+0.10
(+1.88%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Total Assets (Quarterly) : 22.81M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.81M |
| March 31, 2026 | 11.81M |
| December 31, 2025 | 10.48M |
| September 30, 2025 | 3.543M |
| June 30, 2025 | 5.504M |
| March 31, 2025 | 5.310M |
| December 31, 2024 | 2.506M |
| September 30, 2024 | 0.6736M |
| June 30, 2024 | 2.813M |
| March 31, 2024 | 4.754M |
| Date | Value |
|---|---|
| December 31, 2023 | 5.952M |
| September 30, 2023 | 7.376M |
| June 30, 2023 | 8.837M |
| March 31, 2023 | 10.44M |
| December 31, 2022 | 8.654M |
| September 30, 2022 | 9.382M |
| June 30, 2022 | 0.1735M |
| March 31, 2022 | 0.5524M |
| December 31, 2021 | 0.6516M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.629M |
| Shareholders Equity (Quarterly) | 19.18M |
| Debt to Equity Ratio | 0.0102 |
| Current Ratio | 0.1139 |
| Net Debt Paydown Yield | 5.59% |